Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2023-04-11
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this project is to Identify biomarkers in Magnetoencephalography of normal brain development in healthy adults, premature and term newborns from "a priori" obtained by the classical technique of High Resolution EEG performed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Helium 4 Optically Pumped Magnetometers : a New Generation of Sensors for High Speed Functional Brain Imaging
NCT04615637
Evaluation of Optical Pumping Magnetometer Sensors for MagnetoEncephaloGraphy Imaging
NCT04694313
The Role of MEG in Assessment and Diagnosis In mTBI
NCT03867513
A New Generation of Magnetoencephalographs for High Speed Functional Brain Imaging
NCT06244472
High-field Brain Magnetic Resonance Spectroscopy
NCT02053701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults
Magnetoencephalography
40 minutes of Magnetoencephalography with Optical Pump Magnetometer
full term neonates
Magnetoencephalography
40 minutes of Magnetoencephalography with Optical Pump Magnetometer
premature neonates
Magnetoencephalography
40 minutes of Magnetoencephalography with Optical Pump Magnetometer
pregnant women
Magnetoencephalography
40 minutes of Magnetoencephalography with Optical Pump Magnetometer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetoencephalography
40 minutes of Magnetoencephalography with Optical Pump Magnetometer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 65
* No pathology, no treatment
* No toxicant intake
* For term newborns
* Child between 38 and 42 weeks gestational age on the day of registration
* No pathology, no treatment
* For children born prematurely
* Child between 28 and 36 weeks gestational age on the day of registration
* No pathology, no treatment apart from routine care related to prematurity
* For pregnant women
* Pregnant with between 28 to 40 weeks gestational age on the day of registration
* No pathology, no treatment
Exclusion Criteria
* Patients who cannot stand to stand still for a few minutes.
* Newborn on ventilatory assistance or infusion
* Newborn baby not meeting the age criteria
1 Day
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2021_843_0205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.